| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EDWARDS LIFESCIENCES CORP | 34,611 | 4,173,000 | 26.11% | ||
| 2 | ACADIA PHARMACEUTICALS INC COM | 72,723 | 2,313,000 | 14.47% | ||
| 3 | ARATANA THERAPEUTICS INC COM | 218,515 | 2,045,000 | 12.79% | ||
| 4 | JOHNSON & JOHNSON | 13,000 | 1,536,000 | 9.61% | ||
| 5 | DEXCOM | 14,200 | 1,245,000 | 7.79% | ||
| 6 | LILLY ELI & CO | 13,310 | 1,068,000 | 6.68% | ||
| 7 | TESARO INC | 10,000 | 1,002,000 | 6.27% | ||
| 8 | ZOETIS INC | 15,900 | 827,000 | 5.17% | ||
| 9 | BIOGEN INC | 2,600 | 814,000 | 5.09% | ||
| 10 | ALEXION PHARMACEUTIC | 6,199 | 760,000 | 4.75% | ||
| 11 | REGENERON PHARMACEUTICALS | 500 | 201,000 | 1.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-004106, filed 2016.11.07).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
